The World Health Organization places migraine and migraine headaches as one of the 10 most disabling medical illnesses on Earth. Migraine impact over 37 million men, women and children in the United States alone. For more than 90 percent of those affected, migraine interferes with education, career or social activities. In 2018, the FDA approved four preventive treatments designed specifically for migraine. However, there are still ongoing and upcoming clinical research studies to advance migraine prevention and treatment.
AMR Lexington is currently enrolling volunteers ages 18 to 75 in an investigational migraine clinical study.
Qualified participants must:
- be diagnosed with Episodic Migraine
- have a history of migraine headaches of at least one year
- meet other study criteria
Qualified participants will receive at no cost:
- all study-related care
- lab tests
- investigational medication or placebo
Compensation is available for time and travel. Insurance is not required.
For more information or to see if you qualify, call 859-264-8999 or fill out the form below.
By submitting this information, AMR Lexington has my permission to contact me. My consent allows AMR Lexington to use phone, text, and email messages to contact me. Message and data rates may apply. I may contact AMR Lexington at any time to change these preferences. To be removed or to change your contact preferences, please call an AMR Lexington recruitment specialist at 859-264-8999.